Connect with us

Health

Newly approved drugs in Canada lack key pediatric drug information – News-Medical.Net

Newly approved drugs in Canada lack important pediatric drug information in their product monograph, according to an analysis led by McMaster University and McMaster Children’s Hospital.

Published

on

Reviewed by Emily Henderson, B.Sc.Sep 1 2020
Newly approved drugs in Canada lack important pediatric drug information in their product monograph, according to an analysis led by McMaster University and McMaster Children’s Hospital.
This absence of pediatric information perpetuates “off-label” drug use which could be dangerous for this vulnerable population, say the authors. They add that Canadian regulatory mechanisms are needed to ensure submission of pediatric data by manufacturers when use …

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending